| Literature DB >> 33004323 |
Mohamed Hassanein1, Yeshwanter Radhakrishnan2, John Sedor3, Tushar Vachharajani4, Vidula T Vachharajani5, Joshua Augustine6, Sevag Demirjian7, George Thomas8.
Abstract
COVID-19 is primarily considered a respiratory illness, but the kidney may be one of the targets of SARS-CoV-2 infection, since the virus enters cells through the angiotensin-converting enzyme 2 receptor, which is found in abundance in the kidney. Information on kidney involvement in COVID-19 is limited but is evolving rapidly. This article discusses the pathogenesis of acute kidney injury (AKI) in COVID-19, its optimal management, and the impact of COVID-19 on patients with chronic kidney disease, patients with end-stage kidney disease on dialysis, and kidney transplant recipients.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33004323 DOI: 10.3949/ccjm.87a.20072
Source DB: PubMed Journal: Cleve Clin J Med ISSN: 0891-1150 Impact factor: 2.321